title: Interaction of lipid and carbohydrate metabolism after infusions of lipids or of lipid lowering agents: lack of a direct relationship between free fatty acid concentrations and glucose disposal.
abstract: The present work was planned to study the effects of changes in lipid metabolism irrespective of FFA concentrations (FFA) on the regulation of oxidative and nonoxidative disposal of a glucose infusion during hyperinsulinaemia. Fifteen normal volunteers participated in the 3 protocols, in which 1) Intralipid 2) beta-pyridylcarbinol or 3) isotonic saline were infused during 2 hours. Thereafter, these infusions were discontinued and a two-hour euglycaemic hyperinsulinaemic clamp was performed. All three studies were carried out in combination with indirect calorimetry to measure glucose uptake, and oxidative and nonoxidative glucose disposal (corresponding essentially to glucose storage). Plasma FFA concentrations were 508 +/- 34, 601 +/- 43 and 546 +/- 45 mumol/l in the basal state during the Intralipid, beta-pyridylcarbinol and control protocols. It increased to 960 +/- 71 mumol/l after the Intralipid infusion, fell to 246 +/- 17 mumol/l after the beta-pyridylcarbinol infusion, vs 600 +/- 48 mumol/l in the control. At the end of the glucose-insulin clamp the values were low in the 3 protocols: 263 +/- 17, 233 +/- 19 and 204 +/- 14 mumol/l. Intralipid infusion prior to the clamp protocol induced a suppression of both insulin-mediated glucose uptake (4.91 +/- 0.46 (Intralipid) vs 6.83 +/- 0.63 mg.kg-1.min-1 (saline)) and storage (1.61 +/- 0.34 vs 2.99 +/- 0.53 mg.kg-1.min-1) while beta-pyridylcarbinol infusion induced an increased insulin-mediated glucose uptake (8.58 +/- 0.37 mg.kg-1.min-1) and in glucose storage (4.29 +/- 0.31 mg.kg-1.min-1) (p less than 0.5 vs Intralipid). These changes occurred even though FFA plasma concentrations were similar in the 3 experimental conditions.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Internal Medicine, University Hospital, Lausanne, Switzerland.
authors.forename: H
authors.initials: H
authors.lastname: Kleiber
authors.forename: R
authors.initials: R
authors.lastname: Munger
authors.forename: D
authors.initials: D
authors.lastname: Jallut
authors.forename: L
authors.initials: L
authors.lastname: Tappy
authors.forename: C
authors.initials: C
authors.lastname: Felley
authors.forename: A
authors.initials: A
authors.lastname: Golay
authors.forename: P
authors.initials: P
authors.lastname: Frascarolo
authors.forename: E
authors.initials: E
authors.lastname: Jéquier
authors.forename: J P
authors.initials: JP
authors.lastname: Felber
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D002153:Calorimetry, Indirect; D050260:Carbohydrate Metabolism; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D006003:Glycogen / Q000096:biosynthesis; D006801:Humans; D000960:Hypolipidemic Agents / Q000008:administration & dosage*; D007262:Infusions, Intravenous; D007328:Insulin / Q000097:blood; D050356:Lipid Metabolism; D008055:Lipids / Q000008:administration & dosage; D008297:Male; D009540:Nicotinyl Alcohol / Q000008:administration & dosage*; D010084:Oxidation-Reduction
chemical_list: D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D000960:Hypolipidemic Agents; D007328:Insulin; D008055:Lipids; D006003:Glycogen; D009540:Nicotinyl Alcohol